| View |
|
DR-XY28008
|
Levocetirizine Dihydrochloride
|
Xyzal
|
5mg
|
Film-Coated Tablet
|
Antihistamine
|
UCB Farchim S.A.
|
Switzerland
|
Automatic Renewal
|
24 September 2021
|
31 October 2026
|
| View |
|
DR-XY28009
|
0.5% Bupivacaine (as hydrochloride) in 8% Dextrose
|
Senpivac 0.5% Heavy
|
5mg/80mg per mL
|
Solution for Injection (Spinal)
|
Local Anesthetic
|
HARSON LABORATORIES
|
India
|
Renewal
|
16 August 2022
|
04 November 2027
|
| View |
|
DR-XY28023
|
Amoxicillin (As Trihydrate)
|
Littmox
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 November 2022
|
08 November 2027
|
| View |
|
DR-XY28028
|
Furosemide
|
Pisamor
|
40 mg
|
Tablet
|
Diuretic
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
08 September 2022
|
08 November 2027
|
| View |
|
DR-XY28036
|
Naphazoline Hydrochloride
|
Vasoclear-V
|
120 mcg/mL (0.012 % w/v)
|
Ophthalmic Solution
|
Sympathomimetic used as Decongestant
|
El Laboratories, Inc
|
Philippines
|
Automatic Renewal
|
03 October 2022
|
12 September 2027
|
| View |
|
DR-XY28093
|
Carbamazepine
|
Lestremor
|
200 mg
|
Tablet
|
Anticonvulsant / Antiepileptic
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
28 September 2022
|
25 November 2027
|
| View |
|
DR-XY28110
|
Paracetamol
|
Naprex
|
150 mg / mL (300 mg / 2 mL)
|
Solution For Injection (IM/IV)
|
-
|
Amherst Parenterals, Inc.
|
Philippines
|
Initial (Variation) correction
|
14 July 2022
|
29 November 2027
|
| View |
|
DR-XY28123
|
Loratadine + Betamethasone
|
Claricort
|
5 mg/250 mcg
|
Tablet
|
-
|
Schering Plough S. A. de C.V.
|
Mexico
|
Initial (Variation)
|
04 April 2023
|
04 April 2028
|
| View |
|
DR-XY28136
|
POLYMYXIN B SULFATE NEOMYCIN SULFATE DEXAMETHASONE
|
Unbranded
|
8000 units/3.5mg/1mg per mL
|
Sterile Otic Suspension (Ear Drops)
|
Antibacterial/Corticosteroid
|
e.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
05 January 2024
|
24 February 2029
|
| View |
|
DR-XY28137
|
POLYMYXIN B SULFATE NEOMYCIN SULFATE DEXAMETHASONE
|
Unbranded
|
8000 units/3.5mg/1mg per mL
|
Sterile Ophthalmic Suspension(Eye Drops)
|
Antibacterial/Corticosteroid
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
21 December 2023
|
24 February 2029
|
| View |
|
DR-XY28146
|
Cloxacillin (As Sodium)
|
Unbranded
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Asian Antibiotics, Inc.
|
Philippines
|
Renewal
|
08 December 2022
|
01 December 2027
|
| View |
|
DR-XY28147
|
Dexamethasone Phosphate (As Sodium)
|
Dexticort
|
4 mg/mL
|
Solution For Injection (Im/Iv)
|
Corticosteroids
|
L.B.S. Laboratory Limited Partnership
|
Thailand
|
Automatic Renewal
|
02 February 2022
|
10 December 2027
|
| View |
|
DR-XY28161
|
Clavoxel
|
Co-Amoxiclav
|
250 mg/62.5 mg per 5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin-Beta-Lactamse Inhibitor combination)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 November 2022
|
18 December 2027
|
| View |
|
DR-XY28164
|
Co-Amoxiclav
|
Clavoxel
|
250 mg/125 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamse Inhibitor Combination)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 November 2022
|
18 December 2027
|
| View |
|
DR-XY28181
|
Drospirenone + Ethinylestradiol
|
Yasmin
|
3mg/ 30mcg
|
Film-Coated Tablet
|
-
|
Bayer Weimar GmbH Und Co. KG
|
Germany
|
Initial (Variation)
|
05 June 2020
|
16 November 2025
|
| View |
|
DR-XY28201
|
Isoxsuprine Hydrochloride
|
Isoxilan
|
5 mg/mL
|
Solution For Injection (IM/IV)
|
Tocolytic (Uterine relaxant)/Vasodilator
|
Amherst Parenterals, Inc.
|
Philippines
|
Automatic Renewal
|
18 November 2022
|
14 January 2028
|
| View |
|
DR-XY28206
|
Sodium Chloride
|
None
|
0.9%
|
Solution For Inhalation
|
Nasal Decongestant
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
Automatic Renewal
|
31 March 2023
|
03 September 2028
|
| View |
|
DR-XY2821
|
Glycerin
|
Unbranded
|
1.955g
|
Pediatric Suppository
|
Laxative
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
25 July 2024
|
29 September 2029
|
| View |
|
DR-XY28224
|
PREDNISOLONE ACETATE
|
Unbranded
|
1%
|
Sterile Ophthalmic Suspension (Drops)
|
Ophthalmologicals (Corticosteroids, Plain)
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
05 January 2024
|
23 February 2029
|
| View |
|
DR-XY28230
|
Famotidine
|
None
|
40 mg
|
Tablet
|
H2 Receptor Antagonist
|
Swisspharma Research Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 March 2021
|
22 January 2026
|